Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment

Breast. 2010 Oct;19(5):432-3; author reply 433-4. doi: 10.1016/j.breast.2010.03.008. Epub 2010 Apr 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bone Density Conservation Agents / adverse effects*
  • Bone Density Conservation Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Diphosphonates / adverse effects*
  • Diphosphonates / therapeutic use
  • Female
  • Humans
  • Imidazoles / adverse effects*
  • Imidazoles / therapeutic use
  • Jaw / pathology*
  • Osteonecrosis / chemically induced*
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid